Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin 600 mg vs Diosmin 900 mg + Hesperidin 100 mg in Chronic Venous Insufficiency
NCT03471910Phase 4Completed
- Sponsor
- Fundação Educacional Serra dos Órgãos
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diosmin in chronic venous insufficiency (CVI), sponsored by Fundação Educacional Serra dos Órgãos. Started Jun 2017; status: completed.
02
Drugs
diosmin
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT03471910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03471910.